Industry News
GTG settles licensing dispute in US
Genetic Technologies (ASX:GTG) has resolved a dispute surrounding a licence to its non-coding DNA patents first awarded in 2004. [ + ]
Govt taking applications for precincts initiative
The Australian life science industry has a chance to apply to be one of up to 10 Industry Innovation Precincts - consortia of businesses and universities aimed at fostering R&D and competitiveness. [ + ]
United Bioresearch appointed Australian distributor for Abiocode
United Bioresearch has announced its appointment as the Australian distributor for Californian-based Abiocode. [ + ]
Biotron releases more data from HCV trial
Biotron has presented some pharmacokinetic data from its phase IIa trial of BIT225 in HCV, showing no evidence of drug resistance growth. [ + ]
pSivida partner gets new PDUFA date for Iluvien
The US FDA will decide by 17 October whether to approve pSivida (ASX:PVA) licensee Alimera’s NDA for Iluvien in diabetic macular edema. [ + ]
Concern over plan to remove or limit patent extensions
AusBiotech has made a submission in response to the Pharmaceutical Patent Review’s (PPR) Draft Report, stating its disappointment at the options provided under recommendation 5 to remove or reduce Australia’s patent extension provisions. [ + ]
Study reveals ancient microbial feasting
The first-ever snapshot of primitive organisms eating each other has been found in ancient fossils examined by a team of scientists at The University of Western Australia (UWA). [ + ]
Screening for Alzheimer’s disease
The development of a blood test for the early detection of Alzheimer’s disease takes a step forward. [ + ]
CPR launches ligand binding assay service for large molecules
Clinical research company CPR Pharma Services has launched a new laboratory in Adelaide to provide a ligand binding assay service for biomarkers, monoclonal antibodies, biosimilars and biologics in early- and late-phase clinical trials. [ + ]
High-speed discovery helps measure greenhouse gases from space
Scientists have discovered how to measure greenhouse gases 200,000 times faster as the result of research by an award-winning PhD student from The University of Western Australia (UWA) and a US team. [ + ]
Alchemia wins US patent for drug discovery platform
Alchemia (ASX:ACL) has secured US patent protection for its VAST small molecule drug discovery platform through to 2025. [ + ]
Schubert steps onto Garvan board
Dr John Schubert has been elected Chairman of the Board at the Garvan. [ + ]
Imugene wins Chinese Linguet patent
Imugene (ASX:IMU) has secured its second patent from an Asian market protecting the use of its Linguet drug-delivery technology for formulations of drugs to prevent bone loss. [ + ]
Qiagen acquires Ingenuity Systems
Qiagen has announced the acquisition of Ingenuity Systems, a provider of software solutions that efficiently and accurately analyse and interpret the biological meaning of genomic data. [ + ]
ResMed posts record profit for March quarter
ResMed (ASX:RMD) grew its March-quarter profit by 31% and revenue by 10%, thanks to strong gains in the Americas region. [ + ]
